# Iom Bioworks Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iom-bioworks-private

- Industry: Biotechnology
- Headquarters: Bengaluru, India
- Website: www.iombio.com/
- Total disclosed funding: $0.5M
- Latest round: Seed (Jun 12, 2025)
- Investors on record: 1

## About

Iom Bioworks Private Limited, based in India, specializes in gut microbiome health, offering advanced insights through their flagship product, IomBio, which utilizes AI-driven analysis to provide personalized health recommendations.Iom Bioworks Private Limited operates in the health technology sector, focusing on gut microbiome analysis and personalized health solutions. Founded in 2022 in Bengaluru, India, by Bipin Kumar and Samik Ghosh, the company has secured a total of INR 40 million in funding through a SEED round led by Inflection Point Ventures on June 12, 2025. The firm has engaged in one significant deal to date, emphasizing its initial growth phase.Iom Bioworks Pvt., Ltd focuses on delivering insights into gut microbiome health through IomBio, which employs artificial intelligence to analyze individual microbiome profiles. This service aims to tackle health concerns such as irritable bowel syndrome (IBS) and sleep disturbances, providing actionable data for users. IomBio primarily targets health-conscious individuals and professionals in North America and Europe, where personalized health solutions are increasingly sought after.Iom Bioworks generates revenue via a subscription-based model for IomBio, offering monthly and annual plans that provide users with tailored insights and health recommendations based on their microbiome analysis. This direct-to-consumer model fosters strong client relationships and ensures a consistent revenue flow, catering to diverse consumers managing various health concerns.Following the recent funding of INR 40 million in June 2025, Iom Bioworks plans to enhance its marketing initiatives, secure intellectual property claims, and develop its core infrastructure. The company aims to scale both its scientific and commercial teams to support its growth strategy. Future product launches and expansions into additional markets are anticipated, although specific release dates and targeted regions have not yet been disclosed.

## Funding rounds

- Seed, Jun 12, 2025, $0.5M — Inflection Point Ventures

## Investors

- Inflection Point Ventures (https://capitalatlas.ai/funds/inflection-point-ventures) — Seed